Tech Company Financing Transactions

InferVision Funding Round

InferVision closed a $140 million Series D funding round on 8/16/2021. Backers included Goldman Sachs and private investors.

Transaction Overview

Company Name
Announced On
8/16/2021
Transaction Type
Venture Equity
Amount
$140,000,000
Round
Series D
Investors

Goldman Sachs (Lead Investor)

Proceeds Purpose
The proceeds will be used for R&D, distribution channels expansion and business development.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1900 Market St. 8th Floor
Philadelphia, PA 19103
USA
Phone
Undisclosed
Email Address
Overview
Infervision is a world's leading high-tech enterprise in medical artificial intelligence. Infervision provides advanced, intelligent, and systematic services to payor, provider, and patients, and truly realizes Advancing Technology, Inspiring Healthcare.
Profile
InferVision LinkedIn Company Profile
Social Media
InferVision Company Twitter Account
Company News
InferVision News
Facebook
InferVision on Facebook
YouTube
InferVision on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kuan Chen
  Kuan Chen LinkedIn Profile  Kuan Chen Twitter Account  Kuan Chen News  Kuan Chen on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/16/2021: Sestra Systems venture capital transaction
Next: 8/16/2021: Chime venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary